Pharmacogenomic analysis of the triplet combination of gemcitabine, oxaliplatin, and cetuximab as salvage therapy for metastatic colorectal cancer (mCRC) patients No significant financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results